Prytime Medical

The Department of Defense (DoD) Joint Trauma System (JTS) recently released a new Clinical Practice Guideline (CPG) for REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta).

Prytime Medical announced the assignment of National Stock Number (NSN) 6515016632913 for its ER-REBOA™ Convenience Kit by the Defense Logistics Information Service (DLIS). The new NSN allows the U.S.

Prytime Medical Devices, Inc. today announced that the first patient has been enrolled in the company's Emergent Truncal Hemorrhage Control Study.

Prytime Medical Devices, Inc. (The REBOA Company™), announced the launch of a new website at www.prytimemedical.com with the goal of being the leading REBOA resource.

Prytime Medical Devices, Inc. (The REBOA Company™), a privately held medical technology company focused on minimally invasive solutions for trauma, has signed an exclusive distribution agreement with Combat Medical Systems as its U.S.

Prytime Medical Devices, Inc. (The REBOA Company™), today announced FDA 510(k) clearance for expanded labeling changes to the ER-REBOA™ Catheter.

Prytime Medical Devices (The REBOA CompanyTM), a private medical device company focused on providing minimally invasive solutions for vascular trauma, today announced the appointment of general and trauma surgeon John B.

Prytime Medical is pleased to announce the launch of the ER-REBOA™ Catheter Convenience Kit.

Prytime Medical, a specialty medical device manufacturer of the ER-REBOA™ Catheter based in Boerne, Texas, has received confirmation from the United States Patent and Trademark Office (USPTO) that the company's P-Tip® has been recognized and...

Company looks forward to targeted market release into Europe beginning early 2017